Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,742,532
+$28,437,311 QoQ
Shares Held
2,196,642
+908.1% QoQ
Ownership
0.836%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#25
of 626 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Derivatives in OGN
reported options exposure · as of Jun 30, 2026CallValue
$8,124,000
CallShares
600,000
PutValue
$6,770,000
PutShares
500,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $847,064,370 across 13 Drug Manufacturers - General names. OGN ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
151,950 | $182,253,403 | |
| 2 | ABBV |
AbbVie Inc.
|
622,946 | $156,758,131 | |
| 3 | JNJ |
Johnson & Johnson
|
584,500 | $148,445,465 | |
| 4 | SNY |
Sanofi
|
2,405,640 | $102,624,602 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
587,082 | $74,171,939 | |
| 6 | BIIB |
Biogen Inc.
|
265,090 | $57,275,345 | |
| 7 | NVO |
Novo Nordisk A S
|
1,109,982 | $53,212,537 | |
| 8 | OGN |
Organon & Co.
This page
|
2,196,642 | $29,742,532 |
All Filings in OGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,124,000 | 600,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $6,770,000 | 500,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $29,742,532 | 2,196,642 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,305,221 | 217,900 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $23,924,791 | 2,240,149 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,727,453 | 1,108,208 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $21,039,465 | 1,412,993 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $6,442,026 | 311,209 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,661,563 | 194,764 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,774,404 | 331,096 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,971,139 | 459,167 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,317,239 | 1,504,913 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $53,724,171 | 2,284,191 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $30,337,900 | 1,086,212 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $30,988,666 | 1,324,302 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $7,923,453 | 234,769 | Shares | Other | 2022-08-15 | |
| 2021-12-31 | $29,453,310 | 967,268 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,986,001 | 274,047 | Shares | Sole | 2021-12-01 | |
| 2021-06-30 | $14,835,933 | 490,282 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||